Biotech columnist Adam Feuerstein answers readers' questions about health-care companies. (Stocks include CYCC, VVUS, CLDX)
Senior columnist Adam Feuerstein explains why Discovery Labs is the next big thing in biotech.
The show must go on, even if the host loses his voice.
New fees from Bank of America revives debate on whether banks can offset revenue losses by charging customers.
These companies thrive on political and economic uncertainty -- two things that are certain for the rest of the year.
Reviews site Yelp is going public today. Investors may want to stay away for a variety of reasons.
These stocks, which go ex-dividend Monday, are rated buy at TheStreet Ratings.
Stocks waver as European markets weaken and investors watch for developments in Greece's bailout.
Philip van Doorn
The nation's community banks had better be prepared for the possibility of a quick spike in rates of up to 400 basis points within the next few years.
These companies recently increased their dividend payouts to shareholders.